BlackRock Fund Advisors’s Repros Therapeutics Inc. RPRX Stock Holding History

BlackRock Fund Advisors’s Portfolio RPRX Stock Details RPRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$80K	Buy	60,822 +2,150	+4%	+$3.74K	﹤0.01%	3662
2016 Q3	$123K	Buy	58,672 +130	+0.2%	+$257	﹤0.01%	3582
2016 Q2	$94K	Sell	58,542 -877	-1%	-$1.68K	﹤0.01%	3686
2016 Q1	$58K	Sell	59,419 -4,222	-7%	-$4.12K	﹤0.01%	3773
2015 Q4	$77K	Buy	63,641 +3,402	+6%	+$10.9K	﹤0.01%	3798
2015 Q3	$448K	Sell	60,239 -1,590	-3%	-$12.2K	﹤0.01%	3251
2015 Q2	$442K	Sell	61,829 -630,636	-91%	-$4.91M	﹤0.01%	3249
2015 Q1	$5.95M	Buy	692,465 +25,700	+4%	+$230K	﹤0.01%	2745
2014 Q4	$6.65M	Buy	666,765 +111,867	+20%	+$954K	﹤0.01%	2698
2014 Q3	$5.49M	Sell	554,898 -29,849	-5%	-$442K	﹤0.01%	2694
2014 Q2	$10.1M	Sell	584,747 -63,583	-10%	-$1.04M	﹤0.01%	2410
2014 Q1	$11.5M	Buy	648,330 +22,929	+4%	+$444K	﹤0.01%	2317
2013 Q4	$11.4M	Sell	625,401 -23,619	-4%	-$446K	﹤0.01%	2313
2013 Q3	$17.4M	Buy	649,020 +183,398	+39%	+$3.93M	0.01%	2046
2013 Q2	$8.59M	Buy	+465,622	New	+$8.22M	﹤0.01%	2345

Other funds holding RPRX

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

SFM

Sphera Funds Management Tel Aviv, Israel $767M AUM 119.71% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

GAI

General American Investors New York $1.69B AUM 40.94% 1-Year Est. Return

AIA

Allegis Investment Advisors Idaho Falls, Idaho $326M AUM 10.36% 1-Year Est. Return

Jacobs Levy Equity Management Florham Park, New Jersey $27.8B AUM 46.46% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

California Public Employees Retirement System Sacramento, California $177B AUM 39.86% 1-Year Est. Return

BlackRock Fund Advisors's RPRX Position: Q4 2016 in Review

BlackRock Fund Advisors increased its Repros Therapeutics Inc. (RPRX) stake by 3.7% in Q4 2016, buying an estimated $3.74K and bringing the position to 60,822 shares worth $80K. The position accounts for ﹤0.01% of the portfolio, ranked #3662.

BlackRock Fund Advisors first reported a position in RPRX in Q2 2013 and has held it in 15 quarters since. The position peaked at $17.4M in Q3 2013. 43 funds tracked by Wall St. Rank hold RPRX as of Q4 2016.

BlackRock Fund Advisors held 60,822 shares of Repros Therapeutics Inc. worth $80K as of Q4 2016.
BlackRock Fund Advisors bought 2,150 Repros Therapeutics Inc. shares in Q4 2016, an estimated $3.74K.
Repros Therapeutics Inc. made up ﹤0.01% of BlackRock Fund Advisors's portfolio in Q4 2016, its #3662 holding.
BlackRock Fund Advisors first reported a position in Repros Therapeutics Inc. in Q2 2013 and has held it in 15 quarters since.
BlackRock Fund Advisors's Repros Therapeutics Inc. position peaked at $17.4M in Q3 2013.
43 funds tracked by Wall St. Rank held Repros Therapeutics Inc. as of Q4 2016.

Based on BlackRock Fund Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.